MANEESH PHARMACEUTICALS LIMITED
Public Limited Indian Non-Government CompanyUnlistedACTIVE compliantCIN: U24230MH1985PLC036952
INDICATIVE PRICEā¹ āLast allotment: 11 Jul 2023
UA Score85/100
CIN
Incorp. Date25 Jul 1985
Paid-up Capitalā¹28.13 Cr
Open Chargesā None
Last AGM11 Jul 2023
PAN
Company Summary
Maneesh Pharmaceuticals Limited (MPL) is engaged in the business of manufacturing pharmaceutical products. MPL offers products such as gels, lotions, ointments, creams, hormone products, beta-lactam pā¦
PharmaFormulations
Incorporation25 Jul 1985
Age41+ years
PANAAACM3635Q
StatusUnlisted
LocationMumbai, Maharashtra
IndustryPharma
šļø Company Audio Brief
1-Minute Company Overview
Listen to key insights ā¢ 1:00 min
š” Quick Investor Summary
š¢
What They Do
Maneesh Pharmaceuticals Limited (MPL) is engaged in the business of manufacturing pharmaceutical products. MPL offers products such as gels, lotions, ...
š
Financial Health
Reporting Between 250 and 1000 cr. in revenue. Currently operating at a more than 5 cr..
š”ļø
Positive Aspects
Maintains active compliance with regulators.
ā ļø
Key Risk
Payment delays in EPF (true). Market competition.
Key Highlights
ā¹Revenue: Between 250 and 1000 cr.
āProfit: More than 5 cr.
ā Bureau defaults on record
ā Pending legal cases filed
ā EPF payment delay: true
ā¹Employees: Between 1001 and 5000
Management Team
PM
PRAVIN MOHANDAS HEGDE
DirectorDIN: 01404954Since 04 May 2017
RV
RASHMI VINAY SAPTE
DirectorDIN: 00334247Since 30 Mar 2007
MR
MANEESH RAMAKANT SAPTE
Whole-time directorDIN: 00020450Since 31 Mar 2023
Show 11 past directors
BB
BHARAT BACHUBAI MERCHANT
DirectorDIN: 00300384Ceased 28 Mar 2018
BN
BHUPINDER NARENDRA GARG
DirectorDIN: 03337727Ceased 19 Jan 2017
RR
RAKESH RADHEYSHYAM JHUNJHUNWALA
DirectorDIN: 00777064Ceased 15 Oct 2010
KK
KISHOR KASHINATH SARDAL
DirectorDIN: 01369391Ceased 25 Feb 2010
SV
SEJAL VISHEK JAIN
Company SecretaryCeased 16 Aug 2022
MA
MANGAL ASHOK KATAKDHOND
Company SecretaryCeased 31 Jul 2014
AS
ADNAN SHABBIR SHAIKH
Company SecretaryCeased 22 Feb 2018
VT
VINIT TANNA
Company SecretaryCeased 17 Jul 2018
SD
SUNIL DATTATRAYA JOSHI
Company SecretaryDIN: 06391444Ceased 29 Jan 2007
AS
ABHISHEK SHRIVASTAVA
Company SecretaryCeased 25 Mar 2009
RS
RAHULDASHRATH SAWALE
Company SecretaryCeased 01 Aug 2013
IPO Pipeline
IPO Tracker
Financial Data
Financial Statements
š Showing 1 year of data. Upgrade to Premium for full 5-year history.
Total Employees
Between 1001 and 5000
CSR Expenditure
Not Specified
Profit & Loss Statement
| Line Item | FY 2022 |
|---|---|
| Net Revenue | ā¹529.11 Cr |
| Total Operating Cost | ā¹126.19 Cr |
| Operating Profit / (Loss) | ā¹110.55 Cr |
| Other Income | ā¹12.97 Cr |
| Depreciation | ā¹8.94 Cr |
| Profit Before Tax | ā¹65.63 Cr |
| Income Tax | -ā¹9.94 L |
| Profit After Tax (PAT) | ā¹65.73 Cr |
Balance Sheet
| Line Item | FY 2022 |
|---|---|
| ASSETS | |
| Non-Current Investments | ā¹30.73 Cr |
| Net Fixed Assets | ā¹57.26 Cr |
| Total Non-Current Assets | ā¹87.40 Cr |
| Cash & Bank Balances | ā¹12.87 Cr |
| Trade Receivables | ā¹45.77 Cr |
| Total Current Assets | ā¹222.65 Cr |
| Total Assets | ā¹367.32 Cr |
| LIABILITIES & EQUITY | |
| Share Capital | ā¹28.13 Cr |
| Reserves & Surplus | ā¹248.52 Cr |
| Total Equity | ā¹276.64 Cr |
| Long-Term Borrowings | ā¹1.38 Cr |
| Deferred Tax (Net) | ā¹0 |
| Total Non-Current Liabilities | ā¹16.68 Cr |
| Short-Term Borrowings | ā¹3.92 Cr |
| Trade Payables | ā¹32.03 Cr |
| Total Current Liabilities | ā¹73.99 Cr |
| Total Debt | ā¹5.30 Cr |
Cash Flow Statement
| Line Item | FY 2022 |
|---|---|
| Operating Cash Flow | ā¹108.24 Cr |
| Investing Cash Flow | -ā¹89.19 Cr |
| Financing Cash Flow | -ā¹10.49 Cr |
| Net Change in Cash | ā¹8.55 Cr |
| Closing Cash Balance | ā¹9.69 Cr |
Analytics
Charts & Ratios
Insufficient data to compute Enterprise Value to EBITDA. CMP or reliable EBITDA metrics missing.
OCF vs PAT Ratio
Revenue & Profit Trend
Key Ratios
Debt & Equity
Cash Flow Breakdown
Key Ratios Table
Regulatory & Legal
Governance & Compliance
Ownership Structure
Capitalization Table
Industry Benchmarking
Peer Comparison
Industry: Pharma ā Formulations
Sample Size: 30 peers (2022 data)
Target Company Ratios vs Industry Median
| Parameter | Company Value | Industry Median | Status |
|---|---|---|---|
| Revenue (ā¹ Cr) | 529.11 | 488.71 | ā² |
| Revenue Growth (%) | 35.41 | 22.12 | ā² |
| EBITDA Margin (%) | 20.89 | 12.96 | ā² |
| Net Margin (%) | 12.42 | 8.79 | ā² |
| Return on Equity (%) | 23.76 | 16.41 | ā² |
| Debt / Equity | 0.02 | 0.02 | ā |
| Inventory / Sales (Days) | 28 | 46.59 | ā² |
| Debtors / Sales (Days) | 31.57 | 58.44 | ā² |
| Payables / Sales (Days) | 22.10 | 49.56 | ā¼ |
| Cash Conversion Cycle (Days) | 37.47 | 66.26 | ā² |
| Sales / Net Fixed Assets | 9.24 | 4.81 | ā² |
Closest Peers by Revenue
| Company Name | CIN | City | Revenue (ā¹) |
|---|---|---|---|
| APOTEX RESEARCH PRIVATE LIMITED | U73100KA2003PTC032103 | BENGALURU | 5,40,16,00,000 |
| OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED | U24230GJ2012PTC072692 | AHMEDABAD | 5,39,17,46,000 |
| MANEESH PHARMACEUTICALS LIMITED | U24230MH1985PLC036952 | Mumbai | 5,29,10,99,000 |
| CAPLIN POINT LABORATORIES LIMITED | L24231TN1990PLC019053 | CHENNAI | 5,28,06,00,000 |
| WANBURY LIMITED | L51900MH1988PLC048455 | RAIGAD | 5,11,18,57,000 |
Market Sentiments
Latest News
Recent News
No recent news found or analyzed for this company.
MCA Filings